ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPRO CORPORATION
  3. Financials
  4. Proceeds from issuance of term debt, net

NIPRO CORPORATION (8086)

Market cap
¥280.3B
P/E ratio
20.6x
Nipro manufactures medical devices, generic pharmaceuticals, and pharma packaging materials, serving healthcare institutions with products like dialysis equipment, syringes, and glass vials.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndProceeds from issuance of term debt, net (Million JPY)YoY (%)
Mar 31, 202588,612+22.08%
Mar 31, 202472,586-36.90%
Mar 31, 2023115,025+87.12%
Mar 31, 202261,470+30.56%
Mar 31, 202147,080-23.93%
Mar 31, 202061,890-30.31%
Mar 31, 201988,813-34.27%
Mar 31, 2018135,110-7.01%
Mar 31, 2017145,298+37.89%
Mar 31, 2016105,369+26.45%
Mar 31, 201583,330

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat